SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-14-052075
Filing Date
2014-07-18
Accepted
2014-07-17 19:21:27
Documents
4
Group Members
INDEX VENTURE ASSOCIATES IV LTDINDEX VENTURE ASSOCIATES V LTDINDEX VENTURES III (DELAWARE) L.P.INDEX VENTURES III (JERSEY) L.P.INDEX VENTURES III PARALLEL ENTREPRENEUR FUND (JERSEY) L.P.INDEX VENTURES IV (JERSEY) LPINDEX VENTURES IV PARALLEL ENTREPRENEUR

Document Format Files

Seq Description Document Type Size
1 SC 13D a14-17346_1sc13d.htm SC 13D 366134
2 EX-99.1 a14-17346_1ex99d1.htm EX-99.1 71130
3 EX-99.2 a14-17346_1ex99d2.htm EX-99.2 53711
4 EX-99.3 a14-17346_1ex99d3.htm EX-99.3 217833
  Complete submission text file 0001104659-14-052075.txt   710833
Mailing Address NO. 1 SEATON PLACE ST. HELIER Y9 JE 8YJ
Business Address NO. 1 SEATON PLACE ST. HELIER Y9 JE 8YJ 441534605643
Index Venture Associates III Ltd (Filed by) CIK: 0001503683 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y9 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8444
Minerva Neurosciences, Inc. (Subject) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88240 | Film No.: 14981425
SIC: 2834 Pharmaceutical Preparations